Orchid Pharma Shares Shot Up 9% on DCGI Approval for UTI Treatment Drug
Shares of Orchid Pharma Ltd shot-up 9% higher on 6 June after the company announced receiving approval from the Drugs Controller General of India (DCGI)...
Tag : DCGI approval
DCGI Approves AstraZeneca’s Drug for Treatment of High-risk Early Breast Cancer
On Friday, the Drugs Controller General of India (DCGI) has given its market approval to the drug Lynparza (Olaparib) as a monotherapy for the adjuvant...
Hetero has received DCGI approval for generic chronic hepatitis C drug
Hetero, the drug firm has said that it has got approval from the regulator DCGI for its generic Sofosbuvir and Velpatasvir combination tablets that are...
Biocon and Quark has received DCGI approval for trials of new eye disease drug
Biocon, the bio pharmaceutical firm and its partner Quark Pharmaceuticals has received the Drug Controller General of India (DCGI)’s approval to proceed with clinical trials...
Stempeutics has got DCGI approval for stem cell based product
Stempeutics Research has got the limited approval from the national drug regulator, DCGI, for its stem cell based product Stempeucel to treat Buerger’s Disease. Cipla,...
Natco receives DCGI approval to launch hepatitis C drug in India
Natco Pharma has got the Drugs Controller General of India’s approval to launch generic version of Gilead Sciences’ hepatitis C treatment drug in India. Natco...